- Global Pharma News & Resources

Press Releases - 2023-02-02

Date Title Company
02-Feb-2023 Carbios successfully concludes CE-PET1 project supported by the French State and operated by ADEME, which demonstrated the application of its PET biorecycling technology to textiles Businesswire
02-Feb-2023 Carbios clôture avec succès le projet CE-PET1 co-financé par l'Etat et opéré par l'ADEME qui a démontré l’application aux textiles de sa technologie de biorecyclage du PET Businesswire
02-Feb-2023 Medical Automation Market is expected to garner a market value of US$ 102.4 billion by 2033 MARKITWIRED
02-Feb-2023 Disposable Insulin-Delivery Device Market expected to expand at a 7.7% value CAGR by 2032 MARKITWIRED
02-Feb-2023 Super Generics Market is expected to reach US$ 415.13 Billion by 2032 MARKITWIRED
02-Feb-2023 Medical Waste Management System Market is expected to reach US$ 15,354.4 Million by 2032 MARKITWIRED
02-Feb-2023 Medical Terahertz Technology Market is expected to increase at a CAGR 17.1% through 2032 MARKITWIRED
02-Feb-2023 Endocrine Testing Market Anticipated to reach US$ 5735 Million by 2032 | FMI MARKITWIRED
02-Feb-2023 Pneuma Respiratory Announces a Novel Platform That Could Revolutionize Smoking Cessation Therapies and Reduced-Risk Nicotine Products Businesswire
02-Feb-2023 America's Frontier Fund Launches Strategic Innovation Group to Support Fund's Mission of Advancing Frontier Technologies in America Businesswire
02-Feb-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of National Vision Holdings, Inc. (EYE) on Behalf of Investors Businesswire
02-Feb-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) on Behalf of Investors Businesswire
02-Feb-2023 Takeda, que repite sólidos resultados en el tercer trimestre del año fiscal 2022, reafirma su crecimiento a largo plazo con el avance de su cartera de productos en desarrollo y dos adquisiciones selectivas Businesswire
02-Feb-2023 Takeda reforça o crescimento de longo prazo por meio do avanço do seu portfólio e duas aquisições específicas, com um terceiro trimestre forte no ano fiscal de 2022 Businesswire
02-Feb-2023 European Authorities Approve Lyophilized S/D Treated Plasma OctaplasLG® for Pre-Hospital Transfusion Businesswire
02-Feb-2023 Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Businesswire
02-Feb-2023 Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023 Businesswire
02-Feb-2023 First Alberta Clinical Site for Study of Psychedelic-Assisted Treatment for Alcohol Use Disorder Approved Businesswire
02-Feb-2023 Takeda stärkt langfristiges Wachstum durch Fortschritte in der Pipeline und zwei gezielte Akquisitionen; erneut ein starkes drittes Quartal im GJ2022 Businesswire
02-Feb-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire